Company intelligence / Profile preview

AllVac

São Paulo, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

AllVac is a Brazilian biotechnology company specializing in the development and production of vaccines and biological products. The company operates a modern manufacturing facility focused on high-quality immunobiologicals for both human and veterinary health. AllVac gained significant prominence through its involvement in the production and distribution of COVID-19 vaccines in the South American market. Beyond manufacturing, the company provides contract manufacturing services and technical consultancy for biotechnology projects. Its business model integrates research, development, and large-scale production to address public health challenges in the region.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Partnerships

Butantan InstituteFiocruz

Beyond the preview

Go deeper on AllVac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AllVac.

Explore the full profile